Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.05

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.05), versus $0.00 reported last year. Revenue for the quarter came in at $8.67 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Piper Sandler's Weekly Focus Idea: Principal Financial Group (PFG)
• American Outdoor Brands (AOUT) Tops Q4 EPS by 14c